Report of the panels on cardiovascular drugs from the drug efficacy study.
D000787:Angina Pectoris / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002740:Chlorothiazide / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004345:Drug Industry; D004349:Drug Packaging; D011307:Drug Prescriptions; D005938:Glucocorticoids / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000188:drug therapy; D007255:Information Services; D010600:Pharmacology; D012110:Reserpine / Q000627:therapeutic use; D012213:Rheumatic Fever / Q000188:drug therapy; D012769:Shock / Q000188:drug therapy; D013566:Sympathomimetics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D004071:Digitalis Glycosides; D005938:Glucocorticoids; D013566:Sympathomimetics; D014665:Vasodilator Agents; D014970:Xanthines; D006852:Hydrochlorothiazide; D002740:Chlorothiazide; D012110:Reserpine